Hillenbrand (HI) 10-Q 2 Feb 22 2022 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Dec. 31, 2021	Apr. 29, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2021
Document Transition Report	false
Entity File Number	001-33794
Entity Registrant Name	HILLENBRAND, INC.
Entity Incorporation, State or Country Code	IN
Entity Tax Identification Number	26-1342272
Entity Address, Address Line One	One Batesville Boulevard
Entity Address, City or Town	Batesville,
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	47006
City Area Code	812
Local Phone Number	934-7500
Title of 12(b) Security	Common Stock, without par value
Trading Symbol	HI
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		72,813,915
Entity Central Index Key	0001417398
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Amendment Flag	false

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net revenue	$ 728.4	$ 692.5
Cost of goods sold	491.1	448.3
Gross profit	237.3	244.2
Operating expenses	128.1	131.6
Amortization expense	13.7	13.6
Loss (gain) on divestitures	3.1	(31.6)
Interest expense	17.9	21.2
Other expense, net	1.1	0.4
Income before income taxes	73.4	109
Income tax expense	23.3	31.3
Consolidated net income	50.1	77.7
Less: Net income attributable to noncontrolling interests	1.1	1.3
Net income attributable to Hillenbrand	$ 49	$ 76.4
Earnings Per Share [Abstract]
Basic earnings per share	$ 0.67	$ 1.01
Diluted earnings per share	$ 0.67	$ 1.01
Weighted average shares outstanding (basic)	72.7	75.3
Weighted average shares outstanding (diluted)	73.5	75.5

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Consolidated net income (loss)	$ 50.1	$ 77.7
Changes in other comprehensive income, net of tax:
Currency translation adjustment	2.4	59.3
Pension and postretirement (net of tax expense of $0.2 and $0.3)	0.7	1.2
Change in net unrealized gain on derivative instruments (net of tax expense of $0.0 and $0.3)	0.7	1.7
Total changes in other comprehensive income, net of tax	3.8	62.2
Consolidated comprehensive income	53.9	139.9
Less: Comprehensive income attributable to noncontrolling interests	1	1.4
Comprehensive income (loss)	$ 52.9	$ 138.5

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Pension and postretirement, tax	$ (0.4)	$ (0.1)
Change in net unrealized gain (loss) on derivative instruments, tax	$ 0.8	$ 0.9

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2021	Sep. 30, 2021
Current Assets
Cash and cash equivalents	$ 447.4	$ 446.1
Trade receivables, net	312.6	323.5
Receivables from long-term manufacturing contracts	133.8	121.9
Inventories, net	441.7	411.6
Prepaid expenses and other current assets	85.5	75.2
Current assets held for sale	0	56.2
Total current assets	1,421	1,434.5
Property, plant, and equipment, net	287.9	295.1
Operating lease right-of-use assets, net	128.1	138.1
Intangible assets, net	900.2	913.9
Goodwill	1,165.9	1,168.6
Other long-term assets	91.5	64.7
Total Assets	3,994.6	4,014.9
Current Liabilities
Trade accounts payable	389.4	361.3
Liabilities from long-term manufacturing contracts and advances	304.3	296.6
Current portion of long-term debt	0	0
Accrued compensation	83.8	123.5
Current liabilities held for sale	0	18.9
Other current liabilities	251.9	234.8
Total current liabilities	1,029.4	1,035.1
Long-term debt	1,213.4	1,212.9
Accrued pension and postretirement healthcare	146.5	151.6
Operating lease liabilities	96.9	105.6
Deferred income taxes	190.4	206.7
Other long-term liabilities	63.4	70.8
Total Liabilities	2,740	2,782.7
Commitments and contingencies (Note 15)
SHAREHOLDERS’ EQUITY
Common stock, no par value (75.8 and 75.8 shares issued, 72.6 and 72.7 shares outstanding)	0	0
Additional paid-in capital	714.8	725.4
Retained earnings	699.1	666.2
Treasury stock (3.2 and 3.1 shares, at cost)	(138.9)	(135.7)
Accumulated other comprehensive loss	(42.4)	(46.3)
Hillenbrand Shareholders’ Equity	1,232.6	1,209.6
Noncontrolling interests	22	22.6
Total Shareholders’ Equity	1,254.6	1,232.2
Total Liabilities and Shareholders’ Equity	$ 3,994.6	$ 4,014.9

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2021	Sep. 30, 2021
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)
Common stock, shares issued	75,800,000	63,900,000
Common stock, shares outstanding	74,700,000	62,300,000
Treasury stock, shares	1,100,000	1,600,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flow - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating Activities
Consolidated net income	$ 50.1	$ 77.7
Adjustments to reconcile consolidated net income to cash provided by operating activities:
Depreciation and amortization	27.9	29.3
Deferred income taxes	(12.3)	14.4
Amortization of deferred financing costs	0.9	1.7
Share-based compensation	5.9	4.2
Net loss on divestiture	3.1	(31.6)
Trade accounts receivable, net and receivables from long-term manufacturing contracts	(4.1)	(32.8)
Inventories, net	(32.1)	(2.1)
Prepaid expenses and other current assets	(1.7)	(5.1)
Trade accounts payable	30.1	(5.5)
accrued compensation, and other current liabilities	(28.3)	9.3
Income taxes payable	12.7	8.1
Defined benefit plan and postretirement funding	(2.3)	(2.3)
Defined benefit plan and postretirement expense	0.5	0.8
Other, net	(5.9)	0.1
Net cash provided by operating activities	44.5	66.2
Investing Activities
Capital expenditures	(9.7)	(5.6)
Proceeds from divestitures, net of cash divested		59.4
Net cash (used in) provided by investing activities	(14.2)	53.8
Financing Activities
Repayments on long-term debt	0	(220)
Proceeds from revolving credit facilities	0	226
Repayments on revolving credit facilities	0	(163)
Payments of dividends on common stock	(15.8)	(16.1)
Repurchases of common stock	(28.9)	0
Proceeds from stock option exercises	14.6	3.2
Payments for employee taxes on net settlement equity awards	(5.7)	(2.9)
Other, net	(1.6)	(1.3)
Net cash used in financing activities	(37.4)	(174.1)
Effect of exchange rates on cash and cash equivalents	4.4	9.7
Net cash flows	(2.7)	(44.4)
Cash, cash equivalents, and restricted cash:
At beginning of period	450.9	311.8
At end of period	$ 448.2	$ 267.4

Consolidated Statements of Ca_2

Consolidated Statements of Cash Flow Cash, Cash Equivalents, and Restricted Cash - USD ($) $ in Millions	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
Supplemental Cash Flow Elements [Abstract]
Cash and cash equivalents	$ 447.4	$ 446.1	$ 265.8
Restricted Cash and Cash Equivalents	0.8		1.6
Total cash, cash equivalents, and restricted cash shown in the Consolidated Statements of Cash Flows	$ 448.2	$ 450.9	$ 267.4	$ 311.8

Consolidated Statements of Shar

Consolidated Statements of Shareholders Equity Statement - USD ($) shares in Millions, $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock	AOCI Attributable to Parent [Member]	Noncontrolling Interests
Balance at Sep. 30, 2020	$ 1,079.4		$ 723.6	$ 481.4	$ (43.2)	$ (102.8)	$ 20.4
Balance, shares at Sep. 30, 2020		75.8			1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total other comprehensive income (loss), net of tax	62.2					62.1	0.1
Consolidated net income	77.7			76.4			1.3
Common stock, shares issued					0.3
Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture	0.3		(10.9)		$ 11.2
Share-based compensation	4.2		4.2
Dividends, Common Stock	(17.5)		0.3	(16.4)			(1.4)
Balance at Dec. 31, 2020	$ 1,206.3		717.2	541.4	$ (32)	(40.7)	20.4
Balance, shares at Dec. 31, 2020		75.8			0.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, dividends, per share, declared (in dollars per share)	$ 0.2150
Balance at Sep. 30, 2021	$ 1,232.2		725.4	666.2	$ (135.7)	(46.3)	22.6
Balance, shares at Sep. 30, 2021		75.8			3.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total other comprehensive income (loss), net of tax	3.8					3.9	(0.1)
Consolidated net income	50.1			49			1.1
Stock Repurchased During Period, Value	$ 28.9
Stock Repurchased During Period, Shares	0.6
Common stock, shares issued					(0.5)
Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture	$ 8.9		(16.8)		$ 25.7
Share-based compensation	5.9		5.9
Dividends, Common Stock	(17.4)		0.3	(16.1)			(1.6)
Balance at Dec. 31, 2021	$ 1,254.6		$ 714.8	$ 699.1	$ (138.9)	$ (42.4)	$ 22
Balance, shares at Dec. 31, 2021		75.8			3.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, dividends, per share, declared (in dollars per share)	$ 0.2175

Background and Basis of Present

Background and Basis of Presentation	3 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation Hillenbrand, Inc. (the “Company” or “Hillenbrand”) is a global diversified industrial company with multiple leading brands that serve a wide variety of industries around the world. The Company strives to provide superior return for our shareholders, exceptional value for our customers, and great professional opportunities for our employees, and to be responsible to our communities through deployment of the Hillenbrand Operating Model (“HOM”). The HOM is a consistent and repeatable framework designed to produce sustainable and predictable results. The HOM describes the Company’s mission, vision, values, and mindset as leaders; applies our management practices in Strategy Management, Segmentation, Lean, Talent Development, and Acquisitions; and prescribes three steps (Understand, Focus, and Grow) designed to make the Company’s businesses both bigger and better. The Company’s goal is to continue developing Hillenbrand as a world-class global diversified industrial company through the deployment of the HOM. Hillenbrand’s portfolio is composed of three reportable operating segments. Advanced Process Solutions designs, develops, manufactures, and services highly engineered industrial equipment and systems around the world. Molding Technology Solutions is a global leader in highly engineered and customized equipment, systems, and service in plastic technology and processing. Batesville is a recognized leader in the death care industry in North America. “Hillenbrand,” the “Company,” “we,” “us,” “our,” and similar words refer to Hillenbrand and its subsidiaries unless context otherwise requires. The accompanying unaudited Consolidated Financial Statements include the accounts of Hillenbrand and its subsidiaries. They also include two subsidiaries where the Company’s ownership percentage is less than 100%. The Company’s fiscal year ends on September 30. Unless otherwise stated, references to years relate to fiscal years. These unaudited Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial statements and therefore do not include all information required in accordance with United States generally accepted accounting principles (“GAAP”). The unaudited Consolidated Financial Statements have been prepared on the same basis as, and should be read in conjunction with, the audited Consolidated Financial Statements and notes thereto included in the Company’s latest Annual Report on Form 10-K for the year ended September 30, 2021, as filed with the SEC on November 17, 2021. In the opinion of management, these Consolidated Financial Statements reflect all adjustments necessary to present a fair statement of the Company’s consolidated financial position and the consolidated results of operations and cash flows as of the dates and for the periods presented and are normal and recurring in nature. The interim period results are subject to variation and are not necessarily indicative of the results of operations to be expected for the full fiscal year. The preparation of the Consolidated Financial Statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of net revenue and expenses during the period. Actual results could differ from those estimates. Examples of such estimates include, but are not limited to, revenue recognition under the over time method, and the establishment of reserves related to customer rebates, doubtful accounts, warranties, early-pay discounts, inventories, income taxes, litigation, self-insurance, and progress toward achievement of performance criteria under incentive compensation programs. On March 11, 2020, the World Health Organization declared the outbreak of the novel strain of coronavirus (“COVID-19”) a global pandemic and recommended containment and mitigation measures worldwide, and the effects of the COVID-19 pandemic and such associated measures on management’s estimates and results of operations through December 31, 2021 are reflected in the Consolidated Financial Statements. Given the unprecedented nature of the ongoing COVID-19 pandemic, the Company cannot reasonably estimate the full extent of the impact that the COVID-19 pandemic will continue to have on its consolidated financial condition, and the consolidated results of operations, and cash flows in the foreseeable future. The ultimate impact of the COVID-19 pandemic on the Company is highly uncertain and will depend on future developments, and such impacts could exist for an extended period of time, even after the ongoing COVID-19 pandemic subsides or if variant strains of the virus further impact the global economy or the Company. Events and changes in circumstances arising after December 31, 2021, including those resulting from the ongoing impacts of the COVID-19 pandemic, will be reflected in management’s estimates for future periods in subsequent periodic filings.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies The significant accounting policies used in preparing the Consolidated Financial Statements are consistent with the accounting policies described in the Company’s Annual Report on Form 10-K as of and for the year ended September 30, 2021, except as described below. Recently Adopted Accounting Standards In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”). ASU 2019-12 clarifies and simplifies accounting for income taxes by eliminating certain exceptions for intraperiod tax allocation principles, the methodology for calculating income tax rates in an interim period, and recognition of deferred taxes for outside basis differences in an investment, among other updates. ASU 2019-12 became effective for the Company’s fiscal year beginning on October 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Consolidated Financial Statements. No other new accounting pronouncements recently adopted or issued had or are expected to have a material impact on the Consolidated Financial Statements.

Revenue Recognition

Revenue Recognition	3 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Net revenue includes gross revenue less sales discounts, customer rebates, sales incentives, and product returns, all of which require the Company to make estimates for the portion of these allowances that have yet to be credited or paid to customers. The Company estimates these allowances using the expected value method, which is based upon historical rates and projections of customer purchases toward contractual rebate thresholds. Contract balances The balance in receivables from long-term manufacturing contracts at December 31, 2021 and September 30, 2021 was $133.8 and $121.9, respectively. The change was driven by the impact of net revenue recognized prior to billings. The balance in the liabilities from long-term manufacturing contracts and advances at December 31, 2021 and September 30, 2021 was $304.3 and $296.6, respectively, and consists primarily of cash payments received or due in advance of satisfying performance obligations. The revenue recognized for the three months ended December 31, 2021 and 2020 related to liabilities from long-term manufacturing contracts and advances as of September 30, 2021 and 2020 was $98.7 and $80.1, respectively. During the three months ended December 31, 2021 and 2020, the adjustments related to performance obligations satisfied in previous periods were immaterial. Transaction price allocated to the remaining performance obligations As of December 31, 2021, the aggregate amount of transaction price of remaining performance obligations for the Company, which corresponds to backlog as defined in Part I, Item 2 of this Form 10-Q, was $1,724.8. Approximately 77% of these performance obligations are expected to be satisfied over the next twelve months, and the remaining performance obligations, primarily within one to three years. Disaggregation of revenue The following tables present net revenue by end market: Three Months Ended December 31, 2021 Three Months Ended December 31, 2020 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total End Market Plastics $ 235.0 $ — $ — $ 235.0 $ 194.7 $ — $ — $ 194.7 Automotive — 49.6 — 49.6 — 36.5 — 36.5 Chemicals 24.2 — — 24.2 19.1 — — 19.1 Consumer goods — 39.7 — 39.7 — 39.0 — 39.0 Food and pharmaceuticals 21.8 — — 21.8 22.8 — — 22.8 Custom molders — 38.3 — 38.3 — 38.9 — 38.9 Packaging — 35.2 — 35.2 — 31.7 — 31.7 Construction — 24.6 — 24.6 — 20.4 — 20.4 Minerals and mining 12.1 — — 12.1 11.9 — — 11.9 Electronics — 14.3 — 14.3 — 18.4 — 18.4 Medical — 20.0 — 20.0 — 21.2 — 21.2 Death care — — 162.5 162.5 — — 164.8 164.8 Other industrial 24.0 27.1 — 51.1 42.3 30.8 — 73.1 Total $ 317.1 $ 248.8 $ 162.5 $ 728.4 $ 290.8 $ 236.9 $ 164.8 $ 692.5 The following tables present net revenue by geography: Three Months Ended December 31, 2021 Three Months Ended December 31, 2020 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Geography Americas $ 63.6 $ 129.1 $ 162.5 $ 355.2 $ 82.1 $ 124.7 $ 164.8 $ 371.6 Asia 168.6 81.6 — 250.2 127.9 73.3 — 201.2 Europe, the Middle East, and Africa 84.9 38.1 — 123.0 80.8 38.9 — 119.7 Total $ 317.1 $ 248.8 $ 162.5 $ 728.4 $ 290.8 $ 236.9 $ 164.8 $ 692.5 The following tables present net revenue by products and services: Three Months Ended December 31, 2021 Three Months Ended December 31, 2020 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Products and Services Equipment $ 231.5 $ 171.8 $ — $ 403.3 $ 197.9 $ 155.1 $ — $ 353.0 Parts and services 85.6 60.3 — 145.9 92.9 65.5 — 158.4 Death care — — 162.5 162.5 — — 164.8 164.8 Other — 16.7 — 16.7 — 16.3 — 16.3 Total $ 317.1 $ 248.8 $ 162.5 $ 728.4 $ 290.8 $ 236.9 $ 164.8 $ 692.5 The following tables present net revenue by timing of transfer: Three Months Ended December 31, 2021 Three Months Ended December 31, 2020 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Timing of Transfer Point in time $ 135.0 $ 246.1 $ 162.5 $ 543.6 $ 146.2 $ 236.9 $ 164.8 $ 547.9 Over time 182.1 2.7 — 184.8 144.6 — — 144.6 Total $ 317.1 $ 248.8 $ 162.5 $ 728.4 $ 290.8 $ 236.9 $ 164.8 $ 692.5

Business Acquisitions and Dives

Business Acquisitions and Divestitures	3 Months Ended
	Dec. 31, 2021
Business Combinations [Abstract]
Business Acquisitions	Acquisitions and Divestitures Assets and liabilities held for sale During the fourth quarter of 2020, the Company announced that it had initiated a plan to divest the TerraSource Global (“TerraSource”) and flow control businesses, which include the Red Valve business (“Red Valve”) which operated within the Advanced Process Solutions reportable operating segment, as these businesses were no longer considered a strategic fit with the Company’s long-term growth plan and operational objectives. As discussed below, the Company completed the sale of Red Valve on December 31, 2020 and TerraSource on October 22, 2021. The Company had determined that these businesses met the criteria to be classified as held for sale, and therefore reclassified the related assets and liabilities as held for sale on the Consolidated Balance Sheets. The following is a summary of the major categories of assets and liabilities that have been classified as held for sale on the Consolidated Balance Sheet at September 30, 2021: Cash and cash equivalents $ 3.5 Trade receivables, net 7.8 Inventories 12.0 Property, plant and equipment, net 12.0 Operating lease right-of-use assets, net 1.9 Intangible assets, net 49.5 Goodwill 12.4 Other assets 4.2 Valuation allowance on disposal group (1) (47.1) Total assets held for sale $ 56.2 Trade accounts payable $ 5.2 Liabilities from long-term manufacturing contracts and advances 7.5 Operating lease liabilities 2.0 Deferred income taxes 1.9 Other liabilities 2.3 Total liabilities held for sale $ 18.9 (1) The Company adjusted the carrying value to fair value less costs to sell for certain assets held for sale during the year ended September 30, 2021. Those assets were sold during the three months ended December 31, 2021. The Company determined that the exit from these businesses did not represent a strategic shift that had a major effect on its Consolidated Results of Operations, and therefore these businesses were not classified as discontinued operations. The results of operations up to the respective dates of sale for these businesses are included within the Advanced Process Solutions reportable operating segment for all periods presented in this quarterly report. Divestitures of Red Valve and TerraSource Global On December 31, 2020, the Company completed the divestiture of Red Valve to DeZURIK, Inc. in a transaction valued at $63.0. The sale included cash proceeds received at closing of $59.4, including working capital adjustments, and a $5.0 note receivable, included within other long-term assets on the Consolidated Balance Sheet. The sale followed the Company’s previously announced intent to exit certain non-strategic, sub-scale businesses, resulting in Red Valve being classified as held for sale at September 30, 2020. As a result of the Red Valve divestiture, the Company recorded a pre-tax gain of $31.6 in the Consolidated Statement of Operations during the three months ended December 31, 2020. The related tax effect resulted in tax expense of $3.8 and was included within income tax expense in the Consolidated Statement of Operations during the three months ended December 31, 2020. The Company incurred $2.9 of transaction costs associated with the sale during the three months ended December 31, 2020, which were recorded within operating expenses in the Consolidated Statement of Operations. On October 22, 2021, the Company completed the divestiture of TerraSource pursuant to a Contribution Agreement (“Agreement”) between the Company and certain affiliated companies of industrial holding company Right Lane Industries (“RLI”). Under the terms of the Agreement, Hillenbrand contributed TerraSource and its subsidiaries to a newly formed entity, TerraSource Holdings, LLC ("Holdings"), with RLI obtaining majority ownership and full operational control of TerraSource. In exchange for contributing the TerraSource business, the Company received consideration in the form of a five-year note with initial principal amount of $25.6, subject to certain adjustments, and also retained a 49% equity interest in Holdings through one of the Company’s indirect wholly-owned subsidiaries. The fair value of the total consideration received by the Company was $27.7 and is recorded within other long-term assets in the Consolidated Balance Sheet. As a result of the divestiture, the Company recorded a pre-tax loss, subject to customary post-closing adjustments, of $3.1 in the Consolidated Statement of Operations during the three months ended December 31, 2021. The Company incurred $0.4 of transaction costs associated with the divestiture during the three months ended December 31, 2021, which were recorded within operating expenses in the Consolidated Statement of Operations. TerraSource’s results of operations were included within the Advanced Process Solutions reportable operating segment until the completion of the divestiture on October 22, 2021. Subsequent to the divestiture, the Company’s equity interest in Holdings is accounted for under the equity method of accounting as prescribed by GAAP.

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	3 Months Ended
	Dec. 31, 2021
Balance Sheet Related Disclosures [Abstract]
Supplemental Balance Sheet Information	Supplemental Consolidated Balance Sheet Information December 31, September 30, Allowance for doubtful accounts $ 26.8 $ 26.0 Warranty reserves $ 24.5 $ 24.2 Accumulated depreciation on property, plant, and equipment $ 389.9 $ 381.6 Inventories, net: Raw materials and components $ 168.8 $ 153.1 Work in process 99.0 104.0 Finished goods 173.9 154.5 Total inventories, net $ 441.7 $ 411.6

Leases

Leases	3 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Leases	LeasesThe Company’s lease portfolio is comprised of operating leases primarily for manufacturing facilities, offices, vehicles, and certain equipment. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on whether the contract conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. Leases are classified as operating or finance leases at the commencement date of the lease. Operating leases are recorded within operating lease right-of-use assets, net, other current liabilities, and operating lease liabilities in the Consolidated Balance Sheets. The Company’s finance leases were insignificant as of December 31, 2021 and September 30, 2021. Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheets. We have elected an accounting policy to combine lease and non-lease components for all leases. Operating lease right-of-use assets, net and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the implicit rate is generally not readily determinable for most leases, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate reflects the estimated rate of interest that the Company would pay to borrow on a collateralized basis over a similar term in a similar economic environment. Lease expense for operating leases is recognized on a straight-line basis over the lease term. Leases may include renewal options, and the renewal option is included in the lease term if the Company concludes that it is reasonably certain that the option will be exercised. A certain number of the Company’s leases contain rent escalation clauses, either fixed or adjusted periodically for inflation of market rates, which are factored into the calculation of lease payments to the extent they are fixed and determinable at lease inception. The Company also has variable lease payments that do not depend on a rate or index, primarily for items such as common area maintenance and real estate taxes, which are recorded as variable costs when incurred. For the three months ended December 31, 2021 and 2020, the Company recognized $8.4 and $8.9 of operating lease expense, respectively, including short-term lease expense and variable lease costs, which were immaterial in each period. The following table presents supplemental Consolidated Balance Sheet information related to the Company’s operating leases: December 31, 2021 September 30, 2021 Operating lease right-of-use assets, net $ 128.1 $ 138.1 Other current liabilities 29.4 30.7 Operating lease liabilities 96.9 105.6 Total operating lease liabilities $ 126.3 $ 136.3 Weighted-average remaining lease term (in years) 7.1 7.2 Weighted-average discount rate 2.2 % 2.1 % As of December 31, 2021, the maturities of the Company’s operating lease liabilities were as follows: 2022 (excluding the three months ended December 31, 2021) $ 24.3 2023 27.4 2024 19.1 2025 12.5 2026 9.9 Thereafter 42.4 Total lease payments 135.6 Less: imputed interest (9.3) Total present value of lease payments $ 126.3 Supplemental Consolidated Statements of Cash Flow information is as follows: Three Months Ended December 31, 2021 2020 Cash paid for amounts included in the measurement of operating lease liabilities $ 9.1 $ 9.7 Operating lease right-of-use assets, net obtained in exchange for new operating lease liabilities (0.3) 4.3

Intangible Assets and Goodwill

Intangible Assets and Goodwill	3 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	Intangible Assets and Goodwill Intangible Assets Intangible assets are stated at the lower of cost or fair value. Intangible assets are amortized on a straight-line basis over periods ranging from three The following tables summarize the carrying amounts and related accumulated amortization for intangible assets as of: December 31, 2021 September 30, 2021 Cost Accumulated Cost Accumulated Finite-lived assets: Customer relationships 798.0 (205.3) 798.8 (195.4) Technology, including patents 138.5 (64.6) 137.6 (62.7) Software 68.6 (60.1) 68.3 (59.4) 1,005.1 (330.0) 1,004.7 (317.5) Indefinite-lived assets: Trade names 225.1 — 226.6 — Total $ 1,230.2 $ (330.0) $ 1,231.3 $ (317.5) The net change in intangible assets during the three months ended December 31, 2021 was driven primarily by amortization and foreign currency adjustments. Goodwill Goodwill is not amortized, but is subject to annual impairment tests. Goodwill has been assigned to reporting units within the reportable operating segments. The Company assesses the carrying value of goodwill annually, or more often if events or changes in circumstances indicate there may be impairment. Impairment testing is performed at a reporting unit level. The following table summarizes the changes in the Company’s goodwill, by reportable operating segment, for the three months ended December 31, 2021: Advanced Process Solutions Molding Technology Solutions Batesville Total Balance as of September 30, 2021 $ 484.9 $ 675.4 $ 8.3 $ 1,168.6 Foreign currency adjustments (4.4) 1.7 — (2.7) Balance as of December 31, 2021 $ 480.5 $ 677.1 $ 8.3 $ 1,165.9

Financing Agreements

Financing Agreements	3 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Financing Agreements	Financing Agreements The following table summarizes Hillenbrand’s current and long-term debt as of the dates reported in the Consolidated Balance Sheets: December 31, September 30, $400.0 senior unsecured notes (1) $ 396.1 $ 395.8 $375.0 senior unsecured notes, net of discount (2) 371.6 371.5 $350.0 senior unsecured notes (3) 345.9 345.8 $100.0 Series A Notes (4) 99.8 99.8 $900.0 revolving credit facility (excluding outstanding letters of credit) — — Total debt 1,213.4 1,212.9 Less: current portion — — Total long-term debt $ 1,213.4 $ 1,212.9 (1) Includes unamortized debt issuance costs of $3.9 and $4.2 at December 31, 2021 and September 30, 2021, respectively. (2) Includes unamortized debt issuance costs of $3.0 and $3.1 at December 31, 2021 and September 30, 2021, respectively. (3) Includes unamortized debt issuance costs of $4.1 and $4.2 at December 31, 2021 and September 30, 2021, respectively. (4) Includes unamortized debt issuance costs of $0.2 and $0.2 at December 31, 2021 and September 30, 2021, respectively. For the three months ended December 31, 2020, the weighted average interest rate was 2.75% for the $500.0 term loan. For the three months ended December 31, 2020, the weighted average interest rate was 2.63% for the $225.0 term loan. With respect to the Revolver, there were no outstanding balances as of December 31, 2021 and September 30, 2021. As of December 31, 2021, the Company had $16.5 in outstanding letters of credit issued and $883.5 of borrowing capacity under the Revolver. $880.6 of this borrowing capacity was immediately available based on the Company’s most restrictive covenant at December 31, 2021. There were no borrowings under the Revolver during the three months ended December 31, 2021. The weighted-average interest rate on borrowings under the Revolver was 2.52% for the three months ended December 31, 2020. The weighted average facility fee was 0.15% and 0.30% for the three months ended December 31, 2021 and 2020, respectively. The Revolver matures on August 28, 2024. Other credit arrangements In the normal course of business, operating companies within the Advanced Process Solutions reportable operating segment provide to certain customers bank guarantees and other credit arrangements in support of performance, warranty, advance payment, and other contractual obligations. This form of trade finance is customary in the industry and, as a result, the Company maintains adequate capacity to provide the guarantees. As of December 31, 2021 and September 30, 2021, the Company had credit arrangements totaling $403.2 and $411.5, respectively, under which $247.9 and $254.0, respectively, was used for guarantees. These arrangements include the Company’s Syndicated €175.0 Letter of Guarantee Facility (as amended, the “L/G Facility Agreement”) and other ancillary credit facilities. The L/G Facility Agreement matures in December 2022, but can be extended to March 2023 under certain conditions. Covenants related to current financing agreements The Company’s Third Amended and Restated Credit Agreement dated August 28, 2019, as subsequently amended on October 8, 2019, January 10, 2020, May 29, 2020, February 2, 2021, and June 14, 2021 (as amended, the “Credit Agreement”) and the Private Shelf Agreement dated as of December 16, 2012 (as amended, the “Shelf Agreement”) contain the following financial covenants for the current quarter: a maximum leverage ratio (as defined in the agreements) of 3.50 to 1.00 and a minimum ratio of EBITDA (as defined in the agreements) to interest expense of 3.00 to 1.00. The L/G Facility Agreement contains a maximum leverage ratio of 3.75 to 1.00 for the current quarter and a minimum ratio of EBITDA to interest expense of 3.00 to 1.00 (both as defined in such agreement). Additionally, the Credit Agreement, the L/G Facility Agreement, and the Shelf Agreement provide the Company with the ability to sell assets and to incur debt at its international subsidiaries under certain conditions. All obligations of the Company arising under the Credit Agreement, the $400.0 of senior unsecured notes due June 2025 (the “2020 Notes”), the $375.0 of senior unsecured notes due September 2026 (the “2019 Notes”), the $350.0 of senior unsecured notes due March 2031 (the “2021 Notes”), the $100.0 of 4.60% Series A unsecured notes (“Series A Notes”), and the L/G Facility Agreement are fully and unconditionally, and jointly and severally, guaranteed by certain of the Company’s domestic subsidiaries. The Credit Agreement, the L/G Facility Agreement, and the Shelf Agreement each contain certain other customary covenants, representations and warranties and events of default. The indentures governing the 2019 Notes, 2020 Notes, and 2021 Notes do not limit the Company’s ability to incur additional indebtedness. They do, however, contain certain covenants that restrict the Company’s ability to incur secured debt and to engage in certain sale and leaseback transactions. The indentures also contain customary events of default. The indentures provide holders of the senior unsecured notes with remedies if the Company fails to perform specific obligations. As of December 31, 2021, Hillenbrand was in compliance with all covenants and there were no events of default.

Retirement Benefits

Retirement Benefits	3 Months Ended
	Dec. 31, 2021
Retirement Benefits [Abstract]
Retirement Benefits	Retirement Benefits Defined Benefit Plans Components of net periodic pension (benefit) cost included in the Consolidated Statements of Operations were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits Three Months Ended December 31, Three Months Ended December 31, 2021 2020 2021 2020 Service costs $ 0.1 $ 0.2 $ 0.5 $ 0.5 Interest costs 1.5 1.5 0.2 0.2 Expected return on plan assets (2.7) (2.7) (0.2) (0.2) Amortization of net loss 0.4 0.5 0.6 0.7 Net periodic pension (benefit) cost $ (0.7) $ (0.5) $ 1.1 $ 1.2 Defined Contribution Plans

Income Taxes

Income Taxes	3 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The effective tax rates for the three months ended December 31, 2021 and 2020 were 31.7% and 28.7%, respectively. The increase in the effective tax rate was primarily driven by an unfavorable geographic mix of pretax income and the divestiture of TerraSource, partially offset by the increased tax benefit on equity compensation.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Earnings Per Share	The dilutive effects of performance-based stock awards were included in the computation of diluted earnings per share at the level the related performance criteria were met through the respective Consolidated Balance Sheet date. Potential dilutive effects, representing approximately 400,000 shares at both December 31, 2021 and 2020, were excluded from the computation of diluted earnings per share as the related performance criteria were not yet met, although the Company expects to meet various levels of criteria in the future. Three Months Ended 2021 2020 Net income attributable to Hillenbrand $ 49.0 $ 76.4 Weighted-average shares outstanding (basic - in millions) 72.7 75.3 Effect of dilutive stock options and other unvested equity awards (in millions) 0.8 0.2 Weighted-average shares outstanding (diluted - in millions) 73.5 75.5 Basic earnings per share $ 0.67 $ 1.01 Diluted earnings per share $ 0.67 $ 1.01 Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions) — 1.4

Other Comprehensive Income (Los

Other Comprehensive Income (Loss)	3 Months Ended
	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of reclassifications of AOCI	Accumulated Other Comprehensive Loss The following tables summarize the changes in the accumulated balances for each component of accumulated other comprehensive loss: Pension and Currency Net Total Noncontrolling Total Balance at September 30, 2021 $ (49.2) $ 13.1 $ (10.2) $ (46.3) Other comprehensive income before reclassifications: Before tax amount — 2.5 0.4 2.9 $ (0.1) $ 2.8 Tax expense — — (0.1) (0.1) — (0.1) After tax amount — 2.5 0.3 2.8 (0.1) 2.7 Amounts reclassified from accumulated other comprehensive loss (1) 0.7 — 0.4 1.1 — 1.1 Net current period other comprehensive income 0.7 2.5 0.7 3.9 $ (0.1) $ 3.8 Balance at December 31, 2021 $ (48.5) $ 15.6 $ (9.5) $ (42.4) (1) Amounts are net of tax. Pension and Currency Net Total Noncontrolling Total Balance at September 30, 2020 $ (69.6) $ (21.1) $ (12.1) $ (102.8) Other comprehensive loss before reclassifications: Before tax amount — 59.2 1.7 60.9 $ 0.1 $ 61.0 Tax benefit — — (0.4) (0.4) — (0.4) After tax amount — 59.2 1.3 60.5 0.1 60.6 Amounts reclassified from accumulated other comprehensive loss (1) 1.2 — 0.4 1.6 — 1.6 Net current period other comprehensive income 1.2 59.2 1.7 62.1 $ 0.1 $ 62.2 Balance at December 31, 2020 $ (68.4) $ 38.1 $ (10.4) $ (40.7) (1) Amounts are net of tax. Reclassifications out of accumulated other comprehensive loss include: Three Months Ended December 31, 2021 Amortization of Pension and (1) (Gain) Loss on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Cost of goods sold $ — $ — $ (0.2) $ (0.2) Other expense, net 0.9 — 0.6 1.5 Total before tax $ 0.9 $ — $ 0.4 $ 1.3 Tax expense (0.2) Total reclassifications for the period, net of tax $ 1.1 Three Months Ended December 31, 2020 Amortization of Pension and (1) Loss (Gain) on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Other expense, net 1.3 — 0.5 1.8 Total before tax $ 1.3 $ — $ 0.5 $ 1.8 Tax expense (0.2) Total reclassifications for the period, net of tax $ 1.6 (1) These accumulated other comprehensive loss components are included in the computation of net periodic pension cost (see Note 9).

Share-Based Compensation

Share-Based Compensation	3 Months Ended
	Dec. 31, 2021
Compensation Related Costs [Abstract]
Share-Based Compensation	Share-Based Compensation The Company has share-based compensation plans under which 15,385,436 shares are registered. As of December 31, 2021, 3,520,727 shares were outstanding under these plans and 8,291,116 shares had been issued, leaving 3,573,593 shares under the Company’s Amended and Restated Stock Incentive Plan available for future issuance. Three Months Ended 2021 2020 Share-based compensation costs $ 5.9 $ 4.2 Less impact of income tax 1.4 1.0 Share-based compensation costs, net of tax $ 4.5 $ 3.2 The Company has share-based compensation with long-term performance-based metrics that are contingent upon the Company’s relative total shareholder return and the creation of shareholder value, as well as time-based awards. Relative total shareholder return is determined by comparing the Company’s total shareholder return during a three-year period to the respective total shareholder returns of companies in a designated stock index. Creation of shareholder value is measured by the cumulative cash returns and final period net operating profit after tax compared to the established hurdle rate over a three-year period. For the performance-based awards contingent upon the creation of shareholder value, compensation expense is adjusted each quarter based upon actual results to date and any changes to forecasted information on each of the separate grants. During the three months ended December 31, 2021, the Company made the following grants: Number of Time-based stock awards 220,804 Performance-based stock awards (maximum that can be earned) 274,381 The Company’s time-based stock awards and performance-based stock awards granted during the three months ended December 31, 2021, had weighted-average grant date fair values of $46.18 and $52.22, respectively. Included in the performance-based stock awards granted during the three months ended December 31, 2021 are 163,861 units whose payout level is based upon the Company’s relative total shareholder return over the three-year measurement period, as described above. These units will be expensed on a straight-line basis over the measurement period and are not subsequently adjusted after the grant date.

Other Income, Net

Other Income, Net	3 Months Ended
	Dec. 31, 2021
Other Nonoperating Income (Expense) [Abstract]
Other Income, Net	Other Expense, Net Three Months Ended 2021 2020 Interest income $ (0.9) $ (0.6) Foreign currency exchange loss (gain), net 0.9 (0.4) Other, net 1.1 1.4 Other expense, net $ 1.1 $ 0.4

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Like most companies, Hillenbrand is involved from time to time in claims, lawsuits, and government proceedings relating to its operations, including environmental, patent infringement, business practices, commercial transactions, product and general liability, workers’ compensation, auto liability, employment, and other matters. The ultimate outcome of these matters cannot be predicted with certainty. An estimated loss from these contingencies is recognized when the Company believes it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated; however, it is difficult to measure the actual loss that might be incurred related to these matters. If a loss is not considered probable and/or cannot be reasonably estimated, the Company is required to make a disclosure if there is at least a reasonable possibility that a significant loss may have been incurred. Legal fees associated with claims and lawsuits are generally expensed as incurred. Claims covered by insurance have in most instances deductibles and self-funded retentions up to $0.5 per occurrence or per claim, depending upon the type of coverage and policy period. For auto, workers’ compensation, and general liability claims in the U.S., outside insurance companies and third-party claims administrators generally assist in establishing individual claim reserves. An independent outside actuary provides estimates of ultimate projected losses, including incurred but not reported claims, which are used to establish reserves for losses. For all other types of claims, reserves are established based upon advice from internal and external counsel and historical settlement information for claims when such amounts are considered probable of payment. The liabilities recorded represent the best estimate of costs that the Company will incur in relation to such exposures, but it is possible that actual costs will differ from those estimates.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The authoritative guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability, developed based upon the best information available in the circumstances. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is broken down into three levels: Level 1: Inputs are quoted prices in active markets for identical assets or liabilities. Level 2: Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) that are observable for the asset or liability, either directly or indirectly. Level 3: Inputs are unobservable for the asset or liability. See the section below titled “Valuation Techniques” for further discussion of how Hillenbrand determines fair value for investments. Carrying Value at December 31, 2021 Fair Value at December 31, 2021 Using Inputs Considered as: Level 1 Level 2 Level 3 Assets: Cash and cash equivalents $ 447.4 $ 447.4 $ — $ — Restricted cash 0.8 0.8 — — Investments in rabbi trust 4.7 4.7 — — Derivative instruments 2.7 — 2.7 — Liabilities: 2021 Notes 350.0 351.6 — — 2020 Notes 400.0 421.1 — — 2019 Notes 374.6 419.7 — — Series A Notes 100.0 — 105.7 — Derivative instruments 2.5 — 2.5 — Carrying Value at September 30, 2021 Fair Value at September 30, 2021 Using Inputs Considered as: Level 1 Level 2 Level 3 Assets: Cash and cash equivalents $ 446.1 $ 446.1 $ — $ — Restricted cash 1.3 1.3 — — Cash and cash equivalents held for sale 3.5 3.5 — — Investments in rabbi trust 4.2 4.2 — — Derivative instruments 1.9 — 1.9 — Liabilities: 2021 Notes 350.0 349.0 — — 2020 Notes 400.0 422.8 — — 2019 Notes 374.6 421.3 — — Series A Notes 100.0 — 107.6 — Derivative instruments 2.5 — 2.5 — Valuation Techniques • Cash and cash equivalents, restricted cash, cash and cash equivalents held for sale, and investments in rabbi trust are classified within Level 1 of the fair value hierarchy. Financial instruments classified as Level 1 are based on quoted market prices in active markets. The types of financial instruments the Company classifies within Level 1 include most bank deposits, money market securities, and publicly traded mutual funds. The Company does not adjust the quoted market price for such financial instruments. • The Company estimates the fair value of foreign currency derivatives using industry accepted models. The significant Level 2 inputs used in the valuation of derivatives include spot rates, forward rates, and volatility. These inputs were obtained from pricing services, broker quotes, and other sources. • The fair values of the Series A Notes were estimated based on internally-developed models, using current market interest rate data for similar issues, as there is no active market for the Series A Notes. • The fair values of the 2021 Notes, 2020 Notes, and 2019 Notes were based on quoted prices in active markets. Derivative instruments The Company has hedging programs in place to manage its currency exposures. The objectives of the Company’s hedging programs are to mitigate exposures in gross margin and non-functional-currency-denominated assets and liabilities. Under these programs, the Company uses derivative financial instruments to manage the economic impact of fluctuations in currency exchange rates. These include foreign currency exchange forward contracts, which generally have terms up to 24 months. The aggregate notional value of derivatives was $203.1 and $186.4 at December 31, 2021 and September 30, 2021, respectively. The derivatives are recorded at fair value primarily in other current assets and other current liabilities in the Consolidated Balance Sheets.

Segment and Geographical Inform

Segment and Geographical Information	3 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Segment and Geographical Information	Segment and Geographical Information The Company currently conducts operations through three reportable operating segments: Advanced Process Solutions, Molding Technology Solutions, and Batesville. The Company’s reportable operating segments maintain separate financial information for which results of operations are evaluated on a regular basis by the Company’s chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company records the direct costs of business operations to the reportable operating segments, including stock-based compensation, asset impairments, restructuring activities, and business acquisition costs. Corporate provides management and administrative services to each reportable operating segment. These services include treasury management, human resources, legal, business development, and other public company support functions such as internal audit, investor relations, financial reporting, and tax compliance. With limited exception for certain professional services and back-office and technology costs, the Company does not allocate these types of corporate expenses to the reportable operating segments. The following tables present financial information for the Company’s reportable operating segments and significant geographical locations: Three Months Ended December 31, 2021 2020 Net revenue Advanced Process Solutions $ 317.1 $ 290.8 Molding Technology Solutions 248.8 236.9 Batesville 162.5 164.8 Total $ 728.4 $ 692.5 Adjusted EBITDA (1) Advanced Process Solutions $ 54.6 $ 48.5 Molding Technology Solutions 51.8 48.4 Batesville 40.5 52.3 Corporate (17.2) (11.2) Net revenue (2) United States $ 315.7 $ 328.7 China 148.7 111.9 Germany 34.2 34.3 India 50.9 41.5 All other countries 178.9 176.1 Total $ 728.4 $ 692.5 (1) Adjusted earnings before interest, income tax, depreciation, and amortization (“adjusted EBITDA”) is a non-GAAP measure used by management to measure segment performance and make operating decisions. (2) The Company attributes net revenue to a geography based upon the location of the end customer. December 31, September 30, Total assets Advanced Process Solutions $ 1,571.4 $ 1,596.5 Molding Technology Solutions 2,103.1 2,103.0 Batesville 229.2 231.5 Corporate 90.9 83.9 Total $ 3,994.6 $ 4,014.9 Tangible long-lived assets, net United States $ 154.4 $ 161.1 Germany 107.0 113.8 China 52.2 53.0 All other countries 102.4 105.3 Total $ 416.0 $ 433.2 The following schedule reconciles reportable operating segment adjusted EBITDA to consolidated net income: Three Months Ended 2021 2020 Adjusted EBITDA: Advanced Process Solutions $ 54.6 $ 48.5 Molding Technology Solutions 51.8 48.4 Batesville 40.5 52.3 Corporate (17.2) (11.2) Less: Interest income (0.9) (0.6) Interest expense 17.9 21.2 Income tax expense 23.3 31.3 Depreciation and amortization 27.9 29.3 Business acquisition, disposition, and integration costs 7.6 9.1 Restructuring and restructuring-related charges 0.7 1.5 Loss (gain) on divestitures 3.1 (31.6) Other — 0.1 Consolidated net income $ 50.1 $ 77.7

Restructuring

Restructuring	3 Months Ended
	Dec. 31, 2021
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring The following schedule details the restructuring charges by reportable operating segment and the classification of those charges in the Consolidated Statements of Operations. Three Months Ended December 31, 2021 Cost of goods sold Operating expenses Total Advanced Process Solutions $ 0.9 $ 0.2 $ 1.1 Molding Technology Solutions 0.1 — 0.1 Batesville — — — Corporate — — — Total $ 1.0 $ 0.2 $ 1.2 Three Months Ended December 31, 2020 Cost of goods sold Operating expenses Total Advanced Process Solutions $ 0.6 $ 0.9 $ 1.5 Molding Technology Solutions 0.1 0.3 0.4 Batesville — 0.2 0.2 Corporate — 0.2 0.2 Total $ 0.7 $ 1.6 $ 2.3 The restructuring charges during the three months ended December 31, 2021 and 2020 related primarily to severance costs. The severance costs within the Molding Technology Solutions reportable operating segment and corporate were primarily related to the ongoing integration of Milacron. At December 31, 2021, $5.8 of restructuring costs were accrued and expected to be paid over the next twelve months. During fiscal 2021, the Company’s wholly-owned subsidiary Coperion GmbH entered into an agreement with its local works council setting forth a restructuring plan related to its manufacturing facilities in Stuttgart and Weingarten, Germany whereby certain operational functions will be shifted to the Company’s operations in Switzerland or to a third party provider (the “Plan”). As a result, the Company expects to incur severance and other related costs of approximately $12.0 to $13.0 and restructuring-related costs of $4.0 to $5.0 related to the Plan. Substantially all of these costs will result in future cash expenditures that are expected to be substantially paid by the end of calendar year 2022. As the employees are required to render service in order to receive termination benefits, the associated liability related to the Plan will be recognized ratably over the future service period. During the three months ended December 31, 2021, the Company recognized $0.9 of expense, and these amounts were included within cost of goods sold and operating expenses in the Company’s Consolidated Statements of Operations. The total liability related to the Plan was $4.2 as of December 31, 2021.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Revenue	Net revenue includes gross revenue less sales discounts, customer rebates, sales incentives, and product returns, all of which require the Company to make estimates for the portion of these allowances that have yet to be credited or paid to customers. The Company estimates these allowances using the expected value method, which is based upon historical rates and projections of customer purchases toward contractual rebate thresholds.
Revenue Recognition, Deferred Revenue	Contract balances The balance in receivables from long-term manufacturing contracts at December 31, 2021 and September 30, 2021 was $133.8 and $121.9, respectively. The change was driven by the impact of net revenue recognized prior to billings. The balance in the liabilities from long-term manufacturing contracts and advances at December 31, 2021 and September 30, 2021 was $304.3 and $296.6, respectively, and consists primarily of cash payments received or due in advance of satisfying performance obligations. The revenue recognized for the three months ended December 31, 2021 and 2020 related to liabilities from long-term manufacturing contracts and advances as of September 30, 2021 and 2020 was $98.7 and $80.1, respectively. During the three months ended December 31, 2021 and 2020, the adjustments related to performance obligations satisfied in previous periods were immaterial.

Revenue Recognition Revenue Rec

Revenue Recognition Revenue Recognition (Tables)	3 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Disaggregation of revenue The following tables present net revenue by end market: Three Months Ended December 31, 2021 Three Months Ended December 31, 2020 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total End Market Plastics $ 235.0 $ — $ — $ 235.0 $ 194.7 $ — $ — $ 194.7 Automotive — 49.6 — 49.6 — 36.5 — 36.5 Chemicals 24.2 — — 24.2 19.1 — — 19.1 Consumer goods — 39.7 — 39.7 — 39.0 — 39.0 Food and pharmaceuticals 21.8 — — 21.8 22.8 — — 22.8 Custom molders — 38.3 — 38.3 — 38.9 — 38.9 Packaging — 35.2 — 35.2 — 31.7 — 31.7 Construction — 24.6 — 24.6 — 20.4 — 20.4 Minerals and mining 12.1 — — 12.1 11.9 — — 11.9 Electronics — 14.3 — 14.3 — 18.4 — 18.4 Medical — 20.0 — 20.0 — 21.2 — 21.2 Death care — — 162.5 162.5 — — 164.8 164.8 Other industrial 24.0 27.1 — 51.1 42.3 30.8 — 73.1 Total $ 317.1 $ 248.8 $ 162.5 $ 728.4 $ 290.8 $ 236.9 $ 164.8 $ 692.5 The following tables present net revenue by geography: Three Months Ended December 31, 2021 Three Months Ended December 31, 2020 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Geography Americas $ 63.6 $ 129.1 $ 162.5 $ 355.2 $ 82.1 $ 124.7 $ 164.8 $ 371.6 Asia 168.6 81.6 — 250.2 127.9 73.3 — 201.2 Europe, the Middle East, and Africa 84.9 38.1 — 123.0 80.8 38.9 — 119.7 Total $ 317.1 $ 248.8 $ 162.5 $ 728.4 $ 290.8 $ 236.9 $ 164.8 $ 692.5 The following tables present net revenue by products and services: Three Months Ended December 31, 2021 Three Months Ended December 31, 2020 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Products and Services Equipment $ 231.5 $ 171.8 $ — $ 403.3 $ 197.9 $ 155.1 $ — $ 353.0 Parts and services 85.6 60.3 — 145.9 92.9 65.5 — 158.4 Death care — — 162.5 162.5 — — 164.8 164.8 Other — 16.7 — 16.7 — 16.3 — 16.3 Total $ 317.1 $ 248.8 $ 162.5 $ 728.4 $ 290.8 $ 236.9 $ 164.8 $ 692.5 The following tables present net revenue by timing of transfer: Three Months Ended December 31, 2021 Three Months Ended December 31, 2020 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Timing of Transfer Point in time $ 135.0 $ 246.1 $ 162.5 $ 543.6 $ 146.2 $ 236.9 $ 164.8 $ 547.9 Over time 182.1 2.7 — 184.8 144.6 — — 144.6 Total $ 317.1 $ 248.8 $ 162.5 $ 728.4 $ 290.8 $ 236.9 $ 164.8 $ 692.5

Business Acquisitions and Div_2

Business Acquisitions and Divestitures (Tables)	3 Months Ended
	Dec. 31, 2021
Business Combinations [Abstract]
Disposal Groups, Including Discontinued Operations	The following is a summary of the major categories of assets and liabilities that have been classified as held for sale on the Consolidated Balance Sheet at September 30, 2021: Cash and cash equivalents $ 3.5 Trade receivables, net 7.8 Inventories 12.0 Property, plant and equipment, net 12.0 Operating lease right-of-use assets, net 1.9 Intangible assets, net 49.5 Goodwill 12.4 Other assets 4.2 Valuation allowance on disposal group (1) (47.1) Total assets held for sale $ 56.2 Trade accounts payable $ 5.2 Liabilities from long-term manufacturing contracts and advances 7.5 Operating lease liabilities 2.0 Deferred income taxes 1.9 Other liabilities 2.3 Total liabilities held for sale $ 18.9 (1) The Company adjusted the carrying value to fair value less costs to sell for certain assets held for sale during the year ended September 30, 2021. Those assets were sold during the three months ended December 31, 2021.

Supplemental Balance Sheet In_2

Supplemental Balance Sheet Information (Tables)	3 Months Ended
	Dec. 31, 2021
Balance Sheet Related Disclosures [Abstract]
Schedule of supplemental balance sheet information	December 31, September 30, Allowance for doubtful accounts $ 26.8 $ 26.0 Warranty reserves $ 24.5 $ 24.2 Accumulated depreciation on property, plant, and equipment $ 389.9 $ 381.6 Inventories, net: Raw materials and components $ 168.8 $ 153.1 Work in process 99.0 104.0 Finished goods 173.9 154.5 Total inventories, net $ 441.7 $ 411.6

Leases (Tables)

Leases (Tables)	3 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Schedule of Supplemental Balance Sheet Information	The following table presents supplemental Consolidated Balance Sheet information related to the Company’s operating leases: December 31, 2021 September 30, 2021 Operating lease right-of-use assets, net $ 128.1 $ 138.1 Other current liabilities 29.4 30.7 Operating lease liabilities 96.9 105.6 Total operating lease liabilities $ 126.3 $ 136.3 Weighted-average remaining lease term (in years) 7.1 7.2 Weighted-average discount rate 2.2 % 2.1 %
Schedule of Operating Lease Liability Maturities	As of December 31, 2021, the maturities of the Company’s operating lease liabilities were as follows: 2022 (excluding the three months ended December 31, 2021) $ 24.3 2023 27.4 2024 19.1 2025 12.5 2026 9.9 Thereafter 42.4 Total lease payments 135.6 Less: imputed interest (9.3) Total present value of lease payments $ 126.3
Schedule of Supplemental Statement of Cash Flow Information	Supplemental Consolidated Statements of Cash Flow information is as follows: Three Months Ended December 31, 2021 2020 Cash paid for amounts included in the measurement of operating lease liabilities $ 9.1 $ 9.7 Operating lease right-of-use assets, net obtained in exchange for new operating lease liabilities (0.3) 4.3

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	3 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The following tables summarize the carrying amounts and related accumulated amortization for intangible assets as of: December 31, 2021 September 30, 2021 Cost Accumulated Cost Accumulated Finite-lived assets: Customer relationships 798.0 (205.3) 798.8 (195.4) Technology, including patents 138.5 (64.6) 137.6 (62.7) Software 68.6 (60.1) 68.3 (59.4) 1,005.1 (330.0) 1,004.7 (317.5) Indefinite-lived assets: Trade names 225.1 — 226.6 — Total $ 1,230.2 $ (330.0) $ 1,231.3 $ (317.5)
Schedule of Goodwill	The following table summarizes the changes in the Company’s goodwill, by reportable operating segment, for the three months ended December 31, 2021: Advanced Process Solutions Molding Technology Solutions Batesville Total Balance as of September 30, 2021 $ 484.9 $ 675.4 $ 8.3 $ 1,168.6 Foreign currency adjustments (4.4) 1.7 — (2.7) Balance as of December 31, 2021 $ 480.5 $ 677.1 $ 8.3 $ 1,165.9

Financing Agreements (Tables)

Financing Agreements (Tables)	3 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Schedule of borrowings under financing agreements	The following table summarizes Hillenbrand’s current and long-term debt as of the dates reported in the Consolidated Balance Sheets: December 31, September 30, $400.0 senior unsecured notes (1) $ 396.1 $ 395.8 $375.0 senior unsecured notes, net of discount (2) 371.6 371.5 $350.0 senior unsecured notes (3) 345.9 345.8 $100.0 Series A Notes (4) 99.8 99.8 $900.0 revolving credit facility (excluding outstanding letters of credit) — — Total debt 1,213.4 1,212.9 Less: current portion — — Total long-term debt $ 1,213.4 $ 1,212.9 (1) Includes unamortized debt issuance costs of $3.9 and $4.2 at December 31, 2021 and September 30, 2021, respectively. (2) Includes unamortized debt issuance costs of $3.0 and $3.1 at December 31, 2021 and September 30, 2021, respectively. (3) Includes unamortized debt issuance costs of $4.1 and $4.2 at December 31, 2021 and September 30, 2021, respectively.

Retirement Benefits (Tables)

Retirement Benefits (Tables)	3 Months Ended
	Dec. 31, 2021
Retirement Benefits [Abstract]
Components of net pension costs	o

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Schedule of computation of basic and diluted earnings per share	Three Months Ended 2021 2020 Net income attributable to Hillenbrand $ 49.0 $ 76.4 Weighted-average shares outstanding (basic - in millions) 72.7 75.3 Effect of dilutive stock options and other unvested equity awards (in millions) 0.8 0.2 Weighted-average shares outstanding (diluted - in millions) 73.5 75.5 Basic earnings per share $ 0.67 $ 1.01 Diluted earnings per share $ 0.67 $ 1.01 Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions) — 1.4

Other Comprehensive Income (L_2

Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of changes in accumulated other comprehensive income (loss) by component	Pension and Currency Net Total Noncontrolling Total Balance at September 30, 2020 $ (69.6) $ (21.1) $ (12.1) $ (102.8) Other comprehensive loss before reclassifications: Before tax amount — 59.2 1.7 60.9 $ 0.1 $ 61.0 Tax benefit — — (0.4) (0.4) — (0.4) After tax amount — 59.2 1.3 60.5 0.1 60.6 Amounts reclassified from accumulated other comprehensive loss (1) 1.2 — 0.4 1.6 — 1.6 Net current period other comprehensive income 1.2 59.2 1.7 62.1 $ 0.1 $ 62.2 Balance at December 31, 2020 $ (68.4) $ 38.1 $ (10.4) $ (40.7)
Schedule of reclassifications of AOCI	Accumulated Other Comprehensive Loss The following tables summarize the changes in the accumulated balances for each component of accumulated other comprehensive loss: Pension and Currency Net Total Noncontrolling Total Balance at September 30, 2021 $ (49.2) $ 13.1 $ (10.2) $ (46.3) Other comprehensive income before reclassifications: Before tax amount — 2.5 0.4 2.9 $ (0.1) $ 2.8 Tax expense — — (0.1) (0.1) — (0.1) After tax amount — 2.5 0.3 2.8 (0.1) 2.7 Amounts reclassified from accumulated other comprehensive loss (1) 0.7 — 0.4 1.1 — 1.1 Net current period other comprehensive income 0.7 2.5 0.7 3.9 $ (0.1) $ 3.8 Balance at December 31, 2021 $ (48.5) $ 15.6 $ (9.5) $ (42.4) (1) Amounts are net of tax. Pension and Currency Net Total Noncontrolling Total Balance at September 30, 2020 $ (69.6) $ (21.1) $ (12.1) $ (102.8) Other comprehensive loss before reclassifications: Before tax amount — 59.2 1.7 60.9 $ 0.1 $ 61.0 Tax benefit — — (0.4) (0.4) — (0.4) After tax amount — 59.2 1.3 60.5 0.1 60.6 Amounts reclassified from accumulated other comprehensive loss (1) 1.2 — 0.4 1.6 — 1.6 Net current period other comprehensive income 1.2 59.2 1.7 62.1 $ 0.1 $ 62.2 Balance at December 31, 2020 $ (68.4) $ 38.1 $ (10.4) $ (40.7) (1) Amounts are net of tax. Reclassifications out of accumulated other comprehensive loss include: Three Months Ended December 31, 2021 Amortization of Pension and (1) (Gain) Loss on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Cost of goods sold $ — $ — $ (0.2) $ (0.2) Other expense, net 0.9 — 0.6 1.5 Total before tax $ 0.9 $ — $ 0.4 $ 1.3 Tax expense (0.2) Total reclassifications for the period, net of tax $ 1.1 Three Months Ended December 31, 2020 Amortization of Pension and (1) Loss (Gain) on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Other expense, net 1.3 — 0.5 1.8 Total before tax $ 1.3 $ — $ 0.5 $ 1.8 Tax expense (0.2) Total reclassifications for the period, net of tax $ 1.6 (1) These accumulated other comprehensive loss components are included in the computation of net periodic pension cost (see Note 9).

Share-Based Compensation (Table

Share-Based Compensation (Tables)	3 Months Ended
	Dec. 31, 2021
Compensation Related Costs [Abstract]
Schedule of stock-based compensation costs	Three Months Ended 2021 2020 Share-based compensation costs $ 5.9 $ 4.2 Less impact of income tax 1.4 1.0 Share-based compensation costs, net of tax $ 4.5 $ 3.2
Schedule of stock-based awards granted in the period	During the three months ended December 31, 2021, the Company made the following grants: Number of Time-based stock awards 220,804 Performance-based stock awards (maximum that can be earned) 274,381

Other Income, Net (Tables)

Other Income, Net (Tables)	3 Months Ended
	Dec. 31, 2021
Other Nonoperating Income (Expense) [Abstract]
Other income and expense	Three Months Ended 2021 2020 Interest income $ (0.9) $ (0.6) Foreign currency exchange loss (gain), net 0.9 (0.4) Other, net 1.1 1.4 Other expense, net $ 1.1 $ 0.4

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Schedule of financial assets and liabilities at carrying value and fair value and the level within the fair value hierarchy	Carrying Value at December 31, 2021 Fair Value at December 31, 2021 Using Inputs Considered as: Level 1 Level 2 Level 3 Assets: Cash and cash equivalents $ 447.4 $ 447.4 $ — $ — Restricted cash 0.8 0.8 — — Investments in rabbi trust 4.7 4.7 — — Derivative instruments 2.7 — 2.7 — Liabilities: 2021 Notes 350.0 351.6 — — 2020 Notes 400.0 421.1 — — 2019 Notes 374.6 419.7 — — Series A Notes 100.0 — 105.7 — Derivative instruments 2.5 — 2.5 — Carrying Value at September 30, 2021 Fair Value at September 30, 2021 Using Inputs Considered as: Level 1 Level 2 Level 3 Assets: Cash and cash equivalents $ 446.1 $ 446.1 $ — $ — Restricted cash 1.3 1.3 — — Cash and cash equivalents held for sale 3.5 3.5 — — Investments in rabbi trust 4.2 4.2 — — Derivative instruments 1.9 — 1.9 — Liabilities: 2021 Notes 350.0 349.0 — — 2020 Notes 400.0 422.8 — — 2019 Notes 374.6 421.3 — — Series A Notes 100.0 — 107.6 — Derivative instruments 2.5 — 2.5 —

Segment and Geographical Info_2

Segment and Geographical Information (Tables)	3 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Schedule of net revenue, adjusted EBITDA, and depreciation and amortization by segment and geographic location	Three Months Ended December 31, 2021 2020 Net revenue Advanced Process Solutions $ 317.1 $ 290.8 Molding Technology Solutions 248.8 236.9 Batesville 162.5 164.8 Total $ 728.4 $ 692.5 Adjusted EBITDA (1) Advanced Process Solutions $ 54.6 $ 48.5 Molding Technology Solutions 51.8 48.4 Batesville 40.5 52.3 Corporate (17.2) (11.2) Net revenue (2) United States $ 315.7 $ 328.7 China 148.7 111.9 Germany 34.2 34.3 India 50.9 41.5 All other countries 178.9 176.1 Total $ 728.4 $ 692.5 (1) Adjusted earnings before interest, income tax, depreciation, and amortization (“adjusted EBITDA”) is a non-GAAP measure used by management to measure segment performance and make operating decisions.
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas	December 31, September 30, Total assets Advanced Process Solutions $ 1,571.4 $ 1,596.5 Molding Technology Solutions 2,103.1 2,103.0 Batesville 229.2 231.5 Corporate 90.9 83.9 Total $ 3,994.6 $ 4,014.9 Tangible long-lived assets, net United States $ 154.4 $ 161.1 Germany 107.0 113.8 China 52.2 53.0 All other countries 102.4 105.3 Total $ 416.0 $ 433.2
Schedule of reconciliation of segment adjusted EBITDA to consolidated net income	The following schedule reconciles reportable operating segment adjusted EBITDA to consolidated net income: Three Months Ended 2021 2020 Adjusted EBITDA: Advanced Process Solutions $ 54.6 $ 48.5 Molding Technology Solutions 51.8 48.4 Batesville 40.5 52.3 Corporate (17.2) (11.2) Less: Interest income (0.9) (0.6) Interest expense 17.9 21.2 Income tax expense 23.3 31.3 Depreciation and amortization 27.9 29.3 Business acquisition, disposition, and integration costs 7.6 9.1 Restructuring and restructuring-related charges 0.7 1.5 Loss (gain) on divestitures 3.1 (31.6) Other — 0.1 Consolidated net income $ 50.1 $ 77.7

Restructuring Schedule of restr

Restructuring Schedule of restructuring charges by line and segment (Tables)	3 Months Ended
	Dec. 31, 2021
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs	The following schedule details the restructuring charges by reportable operating segment and the classification of those charges in the Consolidated Statements of Operations. Three Months Ended December 31, 2021 Cost of goods sold Operating expenses Total Advanced Process Solutions $ 0.9 $ 0.2 $ 1.1 Molding Technology Solutions 0.1 — 0.1 Batesville — — — Corporate — — — Total $ 1.0 $ 0.2 $ 1.2 Three Months Ended December 31, 2020 Cost of goods sold Operating expenses Total Advanced Process Solutions $ 0.6 $ 0.9 $ 1.5 Molding Technology Solutions 0.1 0.3 0.4 Batesville — 0.2 0.2 Corporate — 0.2 0.2 Total $ 0.7 $ 1.6 $ 2.3

Background and Basis of Prese_2

Background and Basis of Presentation - Narrative (Details)	3 Months Ended
	Dec. 31, 2021segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reportable segments	3
Acquired entity subsidiary investments owned percent	100.00%

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Oct. 01, 2019
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Stockholders' equity	$ 1,254.6	$ 1,232.2	$ 1,206.3	$ 1,079.4
Retained Earnings [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Stockholders' equity	699.1	666.2	541.4	481.4
Retained Earnings [Member] | Accounting Standards Update 2018-02 [Member] | Cumulative Effect, Period of Adoption, Adjustment
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Stockholders' equity					$ 6
AOCI Attributable to Parent [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Stockholders' equity	$ (42.4)	$ (46.3)	$ (40.7)	$ (102.8)

Revenue Recognition Narrative (

Revenue Recognition Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Sep. 30, 2021
Revenue from Contract with Customer [Abstract]
Receivables from long-term manufacturing contracts	$ 133.8		$ 121.9
Liabilities from long-term manufacturing contracts and advances	304.3		$ 296.6
Revenue recognized on long-term manufacturing contracts and advances liabilities	$ 98.7	$ 80.1

Revenue Recognition Revenue Rem

Revenue Recognition Revenue Remaining Performance Obligation Narrative (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-04-01 $ in Millions	Dec. 31, 2021USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	6 months
Revenue, Remaining Performance Obligation, Amount	$ 1,724.8
Remaining performance obligation expected to be recognized in the given period (as a percent)	77.00%

Revenue Recognition Revenue by

Revenue Recognition Revenue by End Market (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Net revenue	$ 728.4	$ 692.5
Plastics
Disaggregation of Revenue [Line Items]
Net revenue	235	194.7
Automotive
Disaggregation of Revenue [Line Items]
Net revenue	49.6	36.5
Chemicals
Disaggregation of Revenue [Line Items]
Net revenue	24.2	19.1
Consumer goods
Disaggregation of Revenue [Line Items]
Net revenue	39.7	39
Food and pharmaceuticals
Disaggregation of Revenue [Line Items]
Net revenue	21.8	22.8
Custom molders
Disaggregation of Revenue [Line Items]
Net revenue	38.3	38.9
Construction
Disaggregation of Revenue [Line Items]
Net revenue	35.2	31.7
Packaging
Disaggregation of Revenue [Line Items]
Net revenue	24.6	20.4
Minerals and mining
Disaggregation of Revenue [Line Items]
Net revenue	12.1	11.9
Electronics
Disaggregation of Revenue [Line Items]
Net revenue	14.3	18.4
Medical
Disaggregation of Revenue [Line Items]
Net revenue	20	21.2
Death care
Disaggregation of Revenue [Line Items]
Net revenue	162.5	164.8
Other industrial
Disaggregation of Revenue [Line Items]
Net revenue	51.1	73.1
Advanced Process Solutions
Disaggregation of Revenue [Line Items]
Net revenue	317.1	290.8
Advanced Process Solutions | Plastics
Disaggregation of Revenue [Line Items]
Net revenue	235	194.7
Advanced Process Solutions | Automotive
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Advanced Process Solutions | Chemicals
Disaggregation of Revenue [Line Items]
Net revenue	24.2	19.1
Advanced Process Solutions | Consumer goods
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Advanced Process Solutions | Food and pharmaceuticals
Disaggregation of Revenue [Line Items]
Net revenue	21.8	22.8
Advanced Process Solutions | Custom molders
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Advanced Process Solutions | Construction
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Advanced Process Solutions | Packaging
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Advanced Process Solutions | Minerals and mining
Disaggregation of Revenue [Line Items]
Net revenue	12.1	11.9
Advanced Process Solutions | Electronics
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Advanced Process Solutions | Medical
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Advanced Process Solutions | Death care
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Advanced Process Solutions | Other industrial
Disaggregation of Revenue [Line Items]
Net revenue	24	42.3
Molding Technology Solutions
Disaggregation of Revenue [Line Items]
Net revenue	248.8	236.9
Molding Technology Solutions | Plastics
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Molding Technology Solutions | Automotive
Disaggregation of Revenue [Line Items]
Net revenue	49.6	36.5
Molding Technology Solutions | Chemicals
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Molding Technology Solutions | Consumer goods
Disaggregation of Revenue [Line Items]
Net revenue	39.7	39
Molding Technology Solutions | Food and pharmaceuticals
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Molding Technology Solutions | Custom molders
Disaggregation of Revenue [Line Items]
Net revenue	38.3	38.9
Molding Technology Solutions | Construction
Disaggregation of Revenue [Line Items]
Net revenue	35.2	31.7
Molding Technology Solutions | Packaging
Disaggregation of Revenue [Line Items]
Net revenue	24.6	20.4
Molding Technology Solutions | Minerals and mining
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Molding Technology Solutions | Electronics
Disaggregation of Revenue [Line Items]
Net revenue	14.3	18.4
Molding Technology Solutions | Medical
Disaggregation of Revenue [Line Items]
Net revenue	20	21.2
Molding Technology Solutions | Death care
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Molding Technology Solutions | Other industrial
Disaggregation of Revenue [Line Items]
Net revenue	27.1	30.8
Batesville
Disaggregation of Revenue [Line Items]
Net revenue	162.5	164.8
Batesville | Plastics
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Batesville | Automotive
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Batesville | Chemicals
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Batesville | Consumer goods
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Batesville | Food and pharmaceuticals
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Batesville | Custom molders
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Batesville | Construction
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Batesville | Packaging
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Batesville | Minerals and mining
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Batesville | Electronics
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Batesville | Medical
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Batesville | Death care
Disaggregation of Revenue [Line Items]
Net revenue	162.5	164.8
Batesville | Other industrial
Disaggregation of Revenue [Line Items]
Net revenue	$ 0	$ 0

Revenue Recognition by Geograph

Revenue Recognition by Geographic Markets (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Net revenue	$ 728.4	$ 692.5
Americas
Disaggregation of Revenue [Line Items]
Net revenue	355.2	371.6
Asia
Disaggregation of Revenue [Line Items]
Net revenue	250.2	201.2
Europe, the Middle East, and Africa
Disaggregation of Revenue [Line Items]
Net revenue	123	119.7
Advanced Process Solutions
Disaggregation of Revenue [Line Items]
Net revenue	317.1	290.8
Advanced Process Solutions | Americas
Disaggregation of Revenue [Line Items]
Net revenue	63.6	82.1
Advanced Process Solutions | Asia
Disaggregation of Revenue [Line Items]
Net revenue	168.6	127.9
Advanced Process Solutions | Europe, the Middle East, and Africa
Disaggregation of Revenue [Line Items]
Net revenue	84.9	80.8
Molding Technology Solutions
Disaggregation of Revenue [Line Items]
Net revenue	248.8	236.9
Molding Technology Solutions | Americas
Disaggregation of Revenue [Line Items]
Net revenue	129.1	124.7
Molding Technology Solutions | Asia
Disaggregation of Revenue [Line Items]
Net revenue	81.6	73.3
Molding Technology Solutions | Europe, the Middle East, and Africa
Disaggregation of Revenue [Line Items]
Net revenue	38.1	38.9
Batesville
Disaggregation of Revenue [Line Items]
Net revenue	162.5	164.8
Batesville | Americas
Disaggregation of Revenue [Line Items]
Net revenue	162.5	164.8
Batesville | Asia
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Batesville | Europe, the Middle East, and Africa
Disaggregation of Revenue [Line Items]
Net revenue	$ 0	$ 0

Revenue Recognition Timing of T

Revenue Recognition Timing of Transfer (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Net revenue	$ 728.4	$ 692.5
Point in time
Disaggregation of Revenue [Line Items]
Net revenue	543.6	547.9
Over time
Disaggregation of Revenue [Line Items]
Net revenue	184.8	144.6
Advanced Process Solutions
Disaggregation of Revenue [Line Items]
Net revenue	317.1	290.8
Advanced Process Solutions | Point in time
Disaggregation of Revenue [Line Items]
Net revenue	135	146.2
Advanced Process Solutions | Over time
Disaggregation of Revenue [Line Items]
Net revenue	182.1	144.6
Molding Technology Solutions
Disaggregation of Revenue [Line Items]
Net revenue	248.8	236.9
Molding Technology Solutions | Point in time
Disaggregation of Revenue [Line Items]
Net revenue	246.1	236.9
Molding Technology Solutions | Over time
Disaggregation of Revenue [Line Items]
Net revenue	2.7	0
Batesville
Disaggregation of Revenue [Line Items]
Net revenue	162.5	164.8
Batesville | Point in time
Disaggregation of Revenue [Line Items]
Net revenue	162.5	164.8
Batesville | Over time
Disaggregation of Revenue [Line Items]
Net revenue	$ 0	$ 0

Revenue Recognition Product and

Revenue Recognition Product and Services (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Net revenue	$ 728.4	$ 692.5
Equipment
Disaggregation of Revenue [Line Items]
Net revenue	403.3	353
Parts and services
Disaggregation of Revenue [Line Items]
Net revenue	145.9	158.4
Death care
Disaggregation of Revenue [Line Items]
Net revenue	162.5	164.8
Other
Disaggregation of Revenue [Line Items]
Net revenue	16.7	16.3
Advanced Process Solutions
Disaggregation of Revenue [Line Items]
Net revenue	317.1	290.8
Advanced Process Solutions | Equipment [Member]
Disaggregation of Revenue [Line Items]
Net revenue		197.9
Advanced Process Solutions | Equipment
Disaggregation of Revenue [Line Items]
Net revenue	231.5
Advanced Process Solutions | Parts and services
Disaggregation of Revenue [Line Items]
Net revenue	85.6	92.9
Advanced Process Solutions | Death care
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Advanced Process Solutions | Other
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Molding Technology Solutions
Disaggregation of Revenue [Line Items]
Net revenue	248.8	236.9
Molding Technology Solutions | Equipment [Member]
Disaggregation of Revenue [Line Items]
Net revenue		155.1
Molding Technology Solutions | Equipment
Disaggregation of Revenue [Line Items]
Net revenue	171.8
Molding Technology Solutions | Parts and services
Disaggregation of Revenue [Line Items]
Net revenue	60.3	65.5
Molding Technology Solutions | Death care
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Molding Technology Solutions | Other
Disaggregation of Revenue [Line Items]
Net revenue	16.7	16.3
Batesville
Disaggregation of Revenue [Line Items]
Net revenue	162.5	164.8
Batesville | Equipment
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Batesville | Parts and services
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Batesville | Death care
Disaggregation of Revenue [Line Items]
Net revenue	162.5	164.8
Batesville | Other
Disaggregation of Revenue [Line Items]
Net revenue	$ 0	$ 0

Business Acquisitions and Div_3

Business Acquisitions and Divestitures - Narrative (Details) - USD ($)	Oct. 22, 2021	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020	Jun. 30, 2021
Business Acquisition [Line Items]
Pre-tax gain (loss)		$ (3,100,000)		$ 31,600,000
Red Valve
Business Acquisition [Line Items]
Total transaction value					$ 63,000,000
Proceeds from divestiture of businesses			$ 59,400,000
Trade receivables, net			5,000,000
Pre-tax gain (loss)		(31,600,000)
Tax effect of gain (loss) from disposal		3,800,000
Transaction costs		2,900,000
TerraSource Global
Business Acquisition [Line Items]
Total transaction value	$ 27,700,000
Trade receivables, net	$ 25,600,000		$ 7,800,000
Pre-tax gain (loss)		3,100,000
Transaction costs		$ 400,000
Notes and loans receivable, term (in years)	5 years
TerraSource Global | Subsidiaries
Business Acquisition [Line Items]
Ownership interest retained after disposal, percent	49.00%

Business Acquisitions and Div_4

Business Acquisitions and Divestitures - Disposal Group Balance Sheet Disclosures (Details) - USD ($) $ in Millions	Oct. 22, 2021	Sep. 30, 2021
Disposal Group, Including Discontinued Operation, Assets [Abstract]
Cash and cash equivalents		$ 3.5
TerraSource Global
Disposal Group, Including Discontinued Operation, Assets [Abstract]
Cash and cash equivalents		3.5
Trade receivables, net	$ 25.6	7.8
Inventories		12
Property, plant and equipment, net		12
Operating lease right-of-use assets, net		1.9
Intangible assets, net		49.5
Goodwill		12.4
Other assets		4.2
Valuation allowance on disposal group (1)		(47.1)
Total assets held for sale		56.2
Disposal Group, Including Discontinued Operation, Liabilities [Abstract]
Trade accounts payable		5.2
Liabilities from long-term manufacturing contracts and advances		7.5
Operating lease liabilities		2
Deferred income taxes		1.9
Other liabilities		2.3
Total liabilities held for sale		$ 18.9

Supplemental Balance Sheet In_3

Supplemental Balance Sheet Information - Schedule of supplemental balance sheet information (Details) - USD ($) $ in Millions	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Balance Sheet Related Disclosures [Abstract]
Restricted Cash and Cash Equivalents	$ 0.8		$ 1.6
Allowance for doubtful accounts	26.8	$ 26
Warranty reserves	24.5	24.2
Accumulated depreciation on property, plant, and equipment	389.9	381.6
Inventories, net:
Raw materials and components	168.8	153.1
Work in process	99	104
Finished goods	173.9	154.5
Total inventories, net	$ 441.7	$ 411.6

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating lease expense	$ 8.4	$ 8.9

Leases - Schedule of Supplement

Leases - Schedule of Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Dec. 31, 2021	Sep. 30, 2021
Leases [Abstract]
Operating lease right-of-use assets, net	$ 128.1	$ 138.1
Other current liabilities	29.4	30.7
Operating lease liabilities	96.9	105.6
Total operating lease liabilities	$ 126.3	$ 136.3
Weighted-average remaining lease term (in years)	7 years 1 month 6 days	7 years 2 months 12 days
Weighted-average discount rate	2.20%	2.10%

Leases - Schedule of Operating

Leases - Schedule of Operating Lease Liability Maturities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Sep. 30, 2021
Leases [Abstract]
2022 (excluding the three months ended December 31, 2021)	$ 24.3
2022	27.4
2023	19.1
2024	9.9
Thereafter	42.4
Total lease payments	135.6
Less: imputed interest	(9.3)
Total present value of lease payments	126.3	$ 136.3
2022	$ 12.5

Leases - Schedule fo Supplement

Leases - Schedule fo Supplemental Statement of Cash Flow Information (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 9.1	$ 9.7
Operating lease right-of-use assets, net obtained in exchange for new operating lease liabilities	$ (0.3)	$ 4.3

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Narrative (Details)	3 Months Ended
	Dec. 31, 2021
Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	3 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	21 years

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Dec. 31, 2021	Mar. 31, 2021	Sep. 30, 2021
Intangible Assets [Line Items]
Cost	$ 1,005.1		$ 1,004.7
Accumulated Amortization	(330)		(317.5)
Total	1,230.2	$ 1,231.3
Trade names
Intangible Assets [Line Items]
Indefinite-lived assets:	225.1		226.6
Customer relationships
Intangible Assets [Line Items]
Cost	798		798.8
Accumulated Amortization	(205.3)		(195.4)
Technology, including patents
Intangible Assets [Line Items]
Cost	138.5		137.6
Accumulated Amortization	(64.6)		(62.7)
Software
Intangible Assets [Line Items]
Cost	68.6		68.3
Accumulated Amortization	$ (60.1)		$ (59.4)

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Goodwill (Details) $ in Millions	3 Months Ended
	Dec. 31, 2021USD ($)
Goodwill [Roll Forward]
Balance at the beginning of the period	$ 1,168.6
Foreign currency adjustments	(2.7)
Balance at the end of the period	1,165.9
Advanced Process Solutions
Goodwill [Roll Forward]
Balance at the beginning of the period	484.9
Foreign currency adjustments	(4.4)
Balance at the end of the period	480.5
Molding Technology Solutions
Goodwill [Roll Forward]
Balance at the beginning of the period	675.4
Foreign currency adjustments	1.7
Balance at the end of the period	677.1
Batesville
Goodwill [Roll Forward]
Balance at the beginning of the period	8.3
Foreign currency adjustments	0
Balance at the end of the period	$ 8.3

Financing Agreements - Schedule

Financing Agreements - Schedule of borrowings (Details) - USD ($) $ in Millions	Dec. 31, 2021	Sep. 30, 2021
Debt Instrument [Line Items]
Total debt	$ 1,213.4	$ 1,212.9
Current portion of long-term debt	0	0
Long-term debt	1,213.4	1,212.9
$400.0 senior unsecured notes (1)
Debt Instrument [Line Items]
Total debt	396.1	395.8
Debt Issuance Costs, Line of Credit Arrangements, Gross	3.9	4.2
$375.0 senior unsecured notes, net of discount (2)
Debt Instrument [Line Items]
Total debt	371.6	371.5
Debt Issuance Costs, Line of Credit Arrangements, Gross	3	3.1
$350.0 senior unsecured notes (3)
Debt Instrument [Line Items]
Total debt	345.9	345.8
Debt Issuance Costs, Line of Credit Arrangements, Gross	4.1	4.2
$100.0 Series A Notes (4)
Debt Instrument [Line Items]
Total debt	99.8	99.8
Debt Issuance Costs, Line of Credit Arrangements, Gross	0.2	0.2
$900.0 revolving credit facility (excluding outstanding letters of credit)
Debt Instrument [Line Items]
Total debt	$ 0	$ 0

Financing Agreements - Narrativ

Financing Agreements - Narrative (Details) € in Millions	3 Months Ended		9 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2020	Jun. 30, 2021	Dec. 31, 2021EUR (€)	Sep. 30, 2021USD ($)	Jun. 16, 2020USD ($)	Dec. 15, 2014USD ($)
Debt instrument [Line Items]
Long-term debt	$ 1,213,400,000				$ 1,212,900,000
Covenant terms, maximum ratio of indebtedness to earnings before interest, taxes, depreciation, and amortization			3.50
Covenant terms, minimum ratio of earnings before interest, taxes, depreciation, and amortization to interest expense			3
$500.0 term loan (1)
Debt instrument [Line Items]
Interest rate during period, percent	2.75%
Debt instrument, face amount	$ 500,000,000
$225.0 term loan (5)
Debt instrument [Line Items]
Interest rate during period, percent	2.63%
Debt instrument, face amount	$ 225,000,000
$900.0 revolving credit facility (excluding outstanding letters of credit)
Debt instrument [Line Items]
Interest rate during period, percent	2.52%
Long-term debt	$ 0				0
Letters of credit outstanding, amount	16,500,000
Line of credit facility, remaining borrowing capacity	$ 883,500,000
Weighted average facility fee	0.15%	0.30%
Other Financing Agreements
Debt instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 403,200,000				411.5
Line of credit facility, amount utilized for bank guarantees	247,900,000				254
Other Financing Agreements | Letter of Credit
Debt instrument [Line Items]
Line of credit facility, maximum borrowing capacity | €				€ 175
$375.0 senior unsecured notes, net of discount (2)
Debt instrument [Line Items]
Debt instrument, face amount	375,000,000
Long-term debt	371,600,000				371,500,000
$400.0 senior unsecured notes (1)
Debt instrument [Line Items]
Debt instrument, face amount						$ 400,000,000
Long-term debt	396,100,000				395,800,000
$100.0 Series A Notes (4)
Debt instrument [Line Items]
Debt instrument, face amount							$ 100,000,000
Long-term debt	$ 99,800,000				$ 99,800,000
Debt interest rate, percent							4.60%
L/G Facility Agreement Amendment
Debt instrument [Line Items]
Covenant terms, maximum ratio of indebtedness to earnings before interest, taxes, depreciation, and amortization			3.75
Covenant terms, minimum ratio of earnings before interest, taxes, depreciation, and amortization to interest expense			3

Retirement Benefits (Details)

Retirement Benefits (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
U.S. Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Service costs	$ 0.1	$ 0.2
Interest costs	1.5	1.5
Expected return on plan assets	(2.7)	(2.7)
Amortization of net loss	0.4	0.5
Net periodic pension (benefit) cost	(0.7)	(0.5)
Non-U.S. Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Service costs	0.5	0.5
Interest costs	0.2	0.2
Expected return on plan assets	(0.2)	(0.2)
Amortization of net loss	0.6	0.7
Net periodic pension (benefit) cost	$ 1.1	$ 1.2

Retirement Benefits - Narrative

Retirement Benefits - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Retirement Benefits [Abstract]
Defined Contribution Plan, Cost	$ 4.7	$ 3.7

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Effective income tax rate	31.70%	28.70%

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income per common share
Net income attributable to Hillenbrand	$ 49	$ 76.4
Weighted-average shares outstanding (basic - in millions)	72,700,000	75,300,000
Effect of dilutive stock options and other unvested equity awards (in millions)	800,000	200,000
Weighted-average shares outstanding (diluted - in millions)	73,500,000	75,500,000
Basic earnings per share	$ 0.67	$ 1.01
Diluted earnings per share	$ 0.67	$ 1.01
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions)	0	1,400,000
Performance-based stock awards
Income per common share
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions)	400,000

Earnings Per Share - Narrative

Earnings Per Share - Narrative (Details) - shares	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Antidilutive securities excluded from computation of earnings per share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	0	1,400,000
Performance-based stock awards (maximum that can be earned)
Antidilutive securities excluded from computation of earnings per share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	400,000

Shareholders' Equity - Narrativ

Shareholders' Equity - Narrative (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Cash dividends paid on common stock	$ 15.8	$ 16.1
Treasury Stock
Class of Stock [Line Items]
Common stock, shares issued	0.5	(0.3)

Other Comprehensive Income (L_3

Other Comprehensive Income (Loss) - Schedule of changes in accumulated other comprehensive income (loss) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]
Balance at the beginning of the period	$ (46.3)
Other comprehensive income before reclassifications
Before tax amount	2.8	$ 61
Tax benefit	(0.1)	(0.4)
After tax amount	2.7	60.6
Amounts reclassified from accumulated other comprehensive loss (1)	1.1	1.6
Total changes in other comprehensive income, net of tax	3.8	62.2
Balance at the end of the period	(42.4)
Pension and Postretirement
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]
Balance at the beginning of the period	(49.2)	(69.6)
Other comprehensive income before reclassifications
Before tax amount	0	0
Tax benefit	0	0
After tax amount	0	0
Amounts reclassified from accumulated other comprehensive loss (1)	0.7	1.2
Total changes in other comprehensive income, net of tax	0.7	1.2
Balance at the end of the period	(48.5)	(68.4)
Currency Translation
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]
Balance at the beginning of the period	13.1	(21.1)
Other comprehensive income before reclassifications
Before tax amount	2.5	59.2
Tax benefit	0	0
After tax amount	2.5	59.2
Amounts reclassified from accumulated other comprehensive loss (1)	0	0
Total changes in other comprehensive income, net of tax	2.5	59.2
Balance at the end of the period	15.6	38.1
Net Unrealized Gain (Loss) on Derivative Instruments
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]
Balance at the beginning of the period	(10.2)	(12.1)
Other comprehensive income before reclassifications
Before tax amount	0.4	1.7
Tax benefit	(0.1)	(0.4)
After tax amount	0.3	1.3
Amounts reclassified from accumulated other comprehensive loss (1)	0.4	0.4
Total changes in other comprehensive income, net of tax	0.7	1.7
Balance at the end of the period	(9.5)	(10.4)
Total Attributable to Hillenbrand, Inc.
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]
Balance at the beginning of the period	(46.3)	(102.8)
Other comprehensive income before reclassifications
Before tax amount	2.9	60.9
Tax benefit	(0.1)	(0.4)
After tax amount	2.8	60.5
Amounts reclassified from accumulated other comprehensive loss (1)	1.1	1.6
Total changes in other comprehensive income, net of tax	3.9	62.1
Balance at the end of the period	(42.4)	(40.7)
Noncontrolling Interests
Other comprehensive income before reclassifications
Before tax amount	(0.1)	0.1
Tax benefit	0	0
After tax amount	(0.1)	0.1
Amounts reclassified from accumulated other comprehensive loss (1)	0	0
Total changes in other comprehensive income, net of tax	$ (0.1)	$ 0.1

Other Comprehensive Income (L_4

Other Comprehensive Income (Loss) - Schedule of reclassifications (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Affected Line in the Consolidated Statement of Operations:
Net revenue	$ 728.4	$ 692.5
Cost of Goods and Services Sold	(491.1)	(448.3)
Other expense, net	1.1	0.4
Tax expense	(23.3)	(31.3)
Total reclassifications for the period, net of tax	1.1	1.6
Amortization of Pension and Postretirement
Affected Line in the Consolidated Statement of Operations:
Total reclassifications for the period, net of tax	0.7	1.2
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Affected Line in the Consolidated Statement of Operations:
Total reclassifications for the period, net of tax	0.4	0.4
Reclassifications out of accumulated other comprehensive income (loss)
Affected Line in the Consolidated Statement of Operations:
Cost of Goods and Services Sold	(0.2)
Other expense, net	1.5	1.8
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	1.3	1.8
Tax expense	(0.2)	(0.2)
Total reclassifications for the period, net of tax	1.1	1.6
Reclassifications out of accumulated other comprehensive income (loss) | Accumulated Defined Benefit Plans Adjustment Net Loss Recognized [Member]
Affected Line in the Consolidated Statement of Operations:
Cost of Goods and Services Sold	0
Other expense, net	0.9	1.3
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	0.9	1.3
Reclassifications out of accumulated other comprehensive income (loss) | Accumulated Defined Benefit Plans Adjustment Prior Service Cost Recognized [Member]
Affected Line in the Consolidated Statement of Operations:
Cost of Goods and Services Sold	0
Other expense, net	0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	0	0
Reclassifications out of accumulated other comprehensive income (loss) | Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Affected Line in the Consolidated Statement of Operations:
Cost of Goods and Services Sold	(0.2)
Other expense, net	0.6	0.5
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	$ 0.4	$ 0.5

Share-Based Compensation - Sche

Share-Based Compensation - Schedule of stock-based compensation costs (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Compensation Related Costs [Abstract]
Share-based compensation costs	$ 5.9	$ 4.2
Less impact of income tax	1.4	1
Share-based compensation costs, net of tax	$ 4.5	$ 3.2

Share-Based Compensation - Sc_2

Share-Based Compensation - Schedule of stock-based awards granted (Details)	3 Months Ended
	Dec. 31, 2021shares
Time-based stock awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards granted in period (in shares)	220,804
Performance-based stock awards (maximum that can be earned)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards granted in period (in shares)	274,381

Share-Based Compensation - Narr

Share-Based Compensation - Narrative (Details)	3 Months Ended
	Dec. 31, 2021$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized (in shares)	15,385,436
Number of options of outstanding number (in shares)	3,520,727
Shares issued in period (in shares)	8,291,116
Number of shares available for grant (in shares)	3,573,593
Award vesting period (in years)	3 years
Time-based stock awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options, grant date fair value (in dollars per share) | $ / shares	$ 46.18
Performance-based stock awards (maximum that can be earned)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options, grant date fair value (in dollars per share) | $ / shares	$ 52.22
Performance-based stock awards granted, number of units (in shares)	163,861

Other Income, Net (Details)

Other Income, Net (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Accumulated other comprehensive income (loss) [Line Items]
Net loss on divestiture	$ (3.1)	$ 31.6
Interest Income, Other	(0.9)	(0.6)
Foreign currency exchange loss (gain), net	0.9	(0.4)
Other, net	1.1	1.4
Other expense, net	$ 1.1	$ 0.4

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Millions	3 Months Ended
	Dec. 31, 2021USD ($)
General claims and lawsuits | Minimum
Commitments and Contingencies
Deductibles and self-insured retentions per occurrence or per claim	$ 0.5

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of financial assets and liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Sep. 30, 2021
Assets:
Cash and cash equivalents	$ 447.4	$ 446.1
Restricted Cash	0.8	1.3
Investments in rabbi trust	4.7	4.2
Derivative instruments	2.7	1.9
Liabilities:
Derivative instruments	2.5	2.5
Cash and cash equivalents		3.5
TerraSource Global
Liabilities:
Cash and cash equivalents		3.5
Cash flow hedging | Foreign Exchange Forward
Liabilities:
Derivative, notional amount	203.1	186.4
Level 1
Assets:
Cash and cash equivalents	447.4	446.1
Restricted Cash	0.8	1.3
Investments in rabbi trust	4.7	4.2
Derivative instruments	0	0
Liabilities:
Derivative instruments	0	0
Cash and cash equivalents		3.5
Level 2
Assets:
Cash and cash equivalents		0
Investments in rabbi trust	0	0
Derivative instruments	2.7	1.9
Liabilities:
Derivative instruments	2.5	2.5
Level 3
Assets:
Cash and cash equivalents	0	0
Investments in rabbi trust	0	0
Derivative instruments	0	0
Liabilities:
Derivative instruments	0	0
2021 Notes
Liabilities:
Debt instruments	350	350
2021 Notes | Level 1
Liabilities:
Debt instruments	351.6	349
2021 Notes | Level 3
Liabilities:
Debt instruments	0
2020 Notes
Liabilities:
Debt instruments	400	400
2020 Notes | Level 1
Liabilities:
Debt instruments	421.1	422.8
2020 Notes | Level 2
Liabilities:
Debt instruments	0	0
2020 Notes | Level 3
Liabilities:
Debt instruments		0
2019 Notes
Liabilities:
Debt instruments	374.6	374.6
2019 Notes | Level 1
Liabilities:
Debt instruments	419.7	421.3
2019 Notes | Level 2
Liabilities:
Debt instruments	0	0
2019 Notes | Level 3
Liabilities:
Debt instruments	0	0
Series A Notes
Liabilities:
Debt instruments	100	100
Series A Notes | Level 1
Liabilities:
Debt instruments	0	0
Series A Notes | Level 2
Liabilities:
Debt instruments	105.7	107.6
Series A Notes | Level 3
Liabilities:
Debt instruments	$ 0	$ 0

Segment and Geographical Info_3

Segment and Geographical Information - Schedule of net revenue and assets by segment (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Sep. 30, 2021
Segment and Geographical Information
Net revenue	$ 728.4	$ 692.5
Total assets	3,994.6		$ 4,014.9
Property, plant, and equipment, net	416		433.2
United States
Segment and Geographical Information
Net revenue	315.7	328.7
Property, plant, and equipment, net	154.4		161.1
GERMANY
Segment and Geographical Information
Net revenue	148.7	111.9
Property, plant, and equipment, net	107		113.8
CHINA
Segment and Geographical Information
Net revenue	34.2	34.3
Property, plant, and equipment, net	52.2		53
INDIA
Segment and Geographical Information
Net revenue	50.9	41.5
All other countries
Segment and Geographical Information
Net revenue	178.9	176.1
Property, plant, and equipment, net	102.4		105.3
Operating segments
Segment and Geographical Information
Net revenue	728.4	692.5
Corporate
Segment and Geographical Information
Adjusted EBITDA (1)	(17.2)	(11.2)
Total assets	90.9		83.9
Advanced Process Solutions
Segment and Geographical Information
Net revenue	317.1	290.8
Advanced Process Solutions | Operating segments
Segment and Geographical Information
Adjusted EBITDA (1)	54.6	48.5
Total assets	1,571.4		1,596.5
Molding Technology Solutions
Segment and Geographical Information
Net revenue	248.8	236.9
Molding Technology Solutions | Operating segments
Segment and Geographical Information
Adjusted EBITDA (1)	51.8	48.4
Total assets	2,103.1		2,103
Batesville
Segment and Geographical Information
Net revenue	162.5	164.8
Batesville | Operating segments
Segment and Geographical Information
Adjusted EBITDA (1)	40.5	$ 52.3
Total assets	$ 229.2		$ 231.5

Segment and Geographical Info_4

Segment and Geographical Information - Schedule of reconciliation of segment (Details 2) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Segment and Geographical Information
Interest income	$ (0.9)	$ (0.6)
Interest expense	17.9	21.2
Income tax expense	23.3	31.3
Depreciation and amortization	27.9	29.3
Business acquisition, development, and integration costs	7.6	9.1
Inventory step-up	0.7	1.5
Net loss on divestiture	3.1	(31.6)
Other	0	0.1
Consolidated net income	50.1	77.7
Corporate
Segment and Geographical Information
Adjusted EBITDA (1)	(17.2)	(11.2)
Advanced Process Solutions | Operating segments
Segment and Geographical Information
Adjusted EBITDA (1)	54.6	48.5
Molding Technology Solutions | Operating segments
Segment and Geographical Information
Adjusted EBITDA (1)	51.8	48.4
Batesville | Operating segments
Segment and Geographical Information
Adjusted EBITDA (1)	$ 40.5	$ 52.3

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) - USD ($)	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Restructuring and Related Cost
Restructuring charges	$ 1,200,000	$ 2,300,000
Inventory step-up	700,000	1,500,000
Restructuring reserve, current	5,800,000
Subsidiaries | Coperion GmbH
Restructuring and Related Cost
Restructuring liability	4,200,000
Cost of Sales | Subsidiaries | Coperion GmbH
Restructuring and Related Cost
Restructuring costs	900,000
Minimum | Subsidiaries | Coperion GmbH
Restructuring and Related Cost
Inventory step-up	4,000,000
Severance costs	12,000,000
Maximum | Subsidiaries | Coperion GmbH
Restructuring and Related Cost
Inventory step-up	5,000,000
Severance costs	13,000,000
Corporate
Restructuring and Related Cost
Restructuring charges	0	200,000
Advanced Process Solutions
Restructuring and Related Cost
Restructuring charges	1,100,000	1,500,000
Molding Technology Solutions
Restructuring and Related Cost
Restructuring charges	100,000	400,000
Batesville
Restructuring and Related Cost
Restructuring charges	0	200,000
Cost of goods sold
Restructuring and Related Cost
Restructuring charges	1,000,000	700,000
Cost of goods sold | Corporate
Restructuring and Related Cost
Restructuring charges	0	0
Cost of goods sold | Advanced Process Solutions
Restructuring and Related Cost
Restructuring charges	900,000	600,000
Cost of goods sold | Molding Technology Solutions
Restructuring and Related Cost
Restructuring charges	100,000	100,000
Cost of goods sold | Batesville
Restructuring and Related Cost
Restructuring charges	0	0
Operating expenses
Restructuring and Related Cost
Restructuring charges	200,000	1,600,000
Operating expenses | Corporate
Restructuring and Related Cost
Restructuring charges	0	200,000
Operating expenses | Advanced Process Solutions
Restructuring and Related Cost
Restructuring charges	200,000	900,000
Operating expenses | Molding Technology Solutions
Restructuring and Related Cost
Restructuring charges	0	300,000
Operating expenses | Batesville
Restructuring and Related Cost
Restructuring charges	$ 0	$ 200,000

Uncategorized Items - hi-202112

Label	Element	Value
Proceeds from Divestiture of Businesses, Net of Cash Divested	us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested	$ (4,500,000)